The Use of Micronutrient Supplements Is Not Associated with Better Quality of Life and Disease Activity in Canadian Patients with Systemic Lupus Erythematosus

Objective. Associations between the use of micronutrient supplements (MS) and disease activity, quality of life (QOL), and healthcare resource utilization were studied in a Canadian population of patients with systemic lupus erythematosus (SLE). Methods. QOL was assessed by the Medical Outcomes Stud...

Full description

Saved in:
Bibliographic Details
Published in:Journal of rheumatology 2010-01, Vol.37 (1), p.87-90
Main Authors: AGHDASSI, Elaheh, MORRISON, Stacey, INVESTIGATORS, Hipp, DACOSTA, Deborah, WITHER, Joan, FORTIN, Paul R, LANDOLT-MARTICORENA, Carolina, JIANDONG SU, PINEAU, Christian A, GLADMAN, Dafna, UROWITZ, Murray, POPE, Janet, PESCHKEN, Christine, LUNNET, Canios
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Biological and medical sciences
Calcium, Dietary - therapeutic use
Canada
Dietary Supplements
Diseases of the osteoarticular system
Female
Health Resources - utilization
Health Status
Humans
Lupus Erythematosus, Systemic - diet therapy
Lupus Erythematosus, Systemic - physiopathology
Male
Medical sciences
Micronutrients - therapeutic use
Middle Aged
Quality of Life
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Severity of Illness Index
Treatment Outcome
Vitamin D - therapeutic use
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. Associations between the use of micronutrient supplements (MS) and disease activity, quality of life (QOL), and healthcare resource utilization were studied in a Canadian population of patients with systemic lupus erythematosus (SLE). Methods. QOL was assessed by the Medical Outcomes Study 36-item Short Form. Healthcare resource utilization and disease activity/damage were determined. Results. Of the 259 subjects studied, 53% were MS users and 34% used only calcium/vitamin D. MS users had a higher Systemic Lupus International Collaborating Clinics score and utilized more healthcare resources. Disease activity and QOL were similar between MS users and nonusers. Conclusion. MS are frequently used by patients with SLE and are not associated with concomitant benefit on QOL. MS users utilized more healthcare resources.
ISSN:0315-162X
1499-2752
DOI:10.3899/jrheum.090761